PHS recommended treatment schedules for gonorrhea.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D002675:Child, Preschool; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009878:Ophthalmia Neonatorum / Q000188:drug therapy; D010402:Penicillin G Procaine / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D000198:Spectinomycin / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013830:Thiadiazoles / Q000627:therapeutic use; D013997:Time Factors; D014481:United States; D014492:United States Public Health Service
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D010402:Penicillin G Procaine; D004917:Erythromycin; D000667:Ampicillin; D000198:Spectinomycin; D013752:Tetracycline